Conference

 

DOWNLOAD PROSPECTUS

The start to finish of biologics

 

The Festival of Biologics brings together senior biologics professionals across the value chain to advance the industry to improve patient health. We cover the start to finish of biologics: from discovery to development, to manufacturing and market access.

COMBINED AGENDA COMING SOON

 

The Americas Antibody Congress is America's best space for discussing topics such as protein engineering, bispecifics and mAbs.

AGENDA COMING SOON

 

At The World Immunotherapy Congress we cover themes such as Cell & Gene Therapy, Immune Check inhibitors and AI in oncology.

AGENDA COMING SOON

 

Biosimilars is bringing together leaders to share on sustainability, innovation and biobetters and patient engagement.

AGENDA COMING SOON

 

Previous Speakers

 

Antibody Speakers

Eugene Zhukovsky
Chief Scientific Officer
Biomunex Pharmaceuticals
Eugene Zhukovsky speaking at Festival of Biologics USA
Bernhard Geierstanger
Executive Director, Protein Engineering and Modalities, Discovery Biologics
Merck
Bernhard Geierstanger speaking at Festival of Biologics USA
Caroline Barelle
CEO & Co-Founder
Elasmogen
Caroline Barelle speaking at Festival of Biologics USA
Rebecca Sendak
Head of the Global Large Molecules Research Platform
Sanofi
Rebecca Sendak speaking at Festival of Biologics USA

 

Immunotherapy Speakers

Eric Halioua
President & CEO
PDC*line Pharma
Eric Halioua speaking at Festival of Biologics USA
Philip Arlen
President & CEO
Precision Biologics
Philip Arlen speaking at Festival of Biologics USA
Marya Chaney
Director, Oncology Medical And Early Drug Development
Merck
Marya Chaney speaking at Festival of Biologics USA
Iulia Diaconu
VP Immunotherapy & Pre-clinical Development
Elevate Bio
Iulia Diaconu speaking at Festival of Biologics USA
 

Biosimilars Speakers

Timothy de Gavre
Chief Commercial Officer
Sandoz US
Hillel Cohen speaking at Festival of Biologics USA
Dr Juan Tapia Mendoza
Board Certified Pediatrician
SOMOS Community Care
Sameer Awsare speaking at Festival of Biologics USA
Gillian Woollett
VP, Head Regulatory Strategy and Policy
Samsung Bioepis US
Gillian Woollett speaking at Festival of Biologics USA
Emanuela Lacana
Deputy Director, Office of Therapeutic Biologics and Biosimilars/OND/CDER
FDA
Emanuela Lacana speaking at Festival of Biologics USA
 

 

APPLY TO SPEAK

Stay Up to Date

Join our mailing list to receive exclusive content and offers.

CONFERENCE TOPICS

AI and Machine Learning in Oncology and Biomarkers
Antibodies in Immunotherapy
Armed Antibodies
Biosimilar Development, Manufacturing and Analysis
Biosimilars in Healthcare Policy
Checkpoint Inhibitors
Clinical Trials
CMC, Developability and Manufacturability
Commercialization and Market Access
Commercialization of Biosimilars and Sustainability of the Industry
Neoantigens
New Technology in Screening and Analytics for Antibody Proteins
Non-Oncology Immunotherapy
Novel Indications for Therapeutic Antibodies
Oncolytic Viruses
The Clinical Environment and Real-world Evidence
Tumor Microenvironment
Value and affordability of Biosimilars